Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel hepatitis B vaccines.

A J Zuckerman

    The Journal of Infection
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Developing hepatitis B vaccines has involved four main strategies. Yeast-derived recombinant vaccines show safety and efficacy comparable to plasma-derived vaccines, offering a promising alternative for hepatitis B prevention.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selected Sumaries.

    Acta clinica Belgica·2016
    Same author

    Viral hepatitis and haemophilia: an introduction.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Trials of Live Influenza Vaccine in the Royal Air Force.

    British medical journal·2010
    Same author

    ABO Blood Groups and Acute Respiratory Virus Disease.

    British medical journal·2010
    Same author

    Acute hepatitis.

    British medical journal·2010
    Same author

    Coe (Coxsackie A 21) virus, para-influenza virus and other respiratory virus infections in the R.A.F., 1958-60.

    The Journal of hygiene·2010

    Area of Science:

    • Vaccinology
    • Immunology
    • Biotechnology

    Background:

    • Hepatitis B virus (HBV) infection is a significant global health concern.
    • Vaccine development is crucial for preventing HBV transmission and chronic liver disease.
    • Existing vaccines have limitations, necessitating exploration of novel approaches.

    Purpose of the Study:

    • To review the diverse strategies employed in the development of hepatitis B vaccines.
    • To evaluate the efficacy and safety of different vaccine platforms.
    • To explore future prospects in synthetic vaccine development.

    Main Methods:

    • Analysis of human plasma-derived vaccines.
    • Development and testing of subunit polypeptide vaccines.
    • Production and clinical evaluation of recombinant DNA vaccines (yeast-derived, hybrid vaccinia virus).

    Related Experiment Videos

  • Chemical synthesis of peptide epitopes for vaccine design.

    • Main Results:

    • Plasma-derived vaccines are safe and effective.
    • Yeast-derived recombinant vaccines demonstrate comparable safety and immunogenicity to plasma-derived vaccines in clinical trials.
    • Hybrid vaccinia virus vaccines show potential for immunological priming.
    • Synthetic peptides can elicit antibody responses in animal models.

    Conclusions:

    • Multiple vaccine development avenues for hepatitis B have been successfully explored.
    • Recombinant DNA technology, particularly yeast-derived vaccines, offers a safe and effective alternative.
    • Chemical synthesis of epitopes presents a future possibility for multivalent vaccines against various pathogens.